The principal investigator of SLU's remdesivir trial explains how the antiviral drug works—and why it's a game-changer for COVID-19 patients

Dr. Sarah George has studied infectious diseases for almost 25 years, and she has seen pandemics before, including HIV, H1N1, Ebola, and Zika.


Sign up for the Recap, St. Louis Magazine's email overview of the week's top stories.
Or, check out all of our newsletters.